Trials / Completed
CompletedNCT03500796
Combined Amniotic Membrane and Platelet Rich Plasma Clot for Management of Central Corneal Perforation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Minia University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Use of amniotic membrane(AMT) and platelet rich plasma (PRP) clot for closure of central corneal perforation
Detailed description
Use of amniotic membrane and platelet rich plasma clot for closure of central corneal perforation either post infective or posttraumatic
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Platelet rich plasma clot implantation | Implantation of a platelet rich plasma clot, which is created from the plasma of the patients, and refrigerated to be inserted under the sealing amniotic membrane |
| PROCEDURE | Wound closure with amniotic membrane | Closure of the corneal perforation with a synthetic amniotic membrane with a 2 mm safety margin |
Timeline
- Start date
- 2018-04-15
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2018-04-18
- Last updated
- 2021-05-19
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03500796. Inclusion in this directory is not an endorsement.